In GB tissue, SPRY1 mRNA and protein are significantly upregulated compared to normal brain tissue or lower-grade gliomas, and high SPRY1 levels are related to reduced overall survival of GB patients using the REMBRANDT datasets [58,115,116,117]. This evidence concerns the gene SPRY1 and central nervous system cancer.